Winmill & Co’s Nu Skin NUS Stock Holding History

Winmill & Co’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-108,100	Closed	-$4.38M	–	84
2021 Q3	$4.38M	Buy	108,100 +54,050	+100%	+$2.73M	1.4%	29
2021 Q2	$3.06M	Hold	54,050	–	–	1.1%	44
2021 Q1	$2.86M	Buy	+54,050	New	+$2.94M	1.05%	47

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Winmill & Co's NUS Position: Q4 2021 in Review

Winmill & Co sold out of Nu Skin (NUS) in Q4 2021, closing a stake of 108,100 shares — an estimated $4.38M sold.

Winmill & Co first reported a position in NUS in Q1 2021 and held it in 3 quarters. The position peaked at $4.38M in Q3 2021. 258 funds tracked by Wall St. Rank hold NUS as of Q4 2021.

Winmill & Co reported no remaining Nu Skin position as of Q4 2021 after selling out during the quarter.
Winmill & Co sold 108,100 Nu Skin shares in Q4 2021, an estimated $4.38M.
Winmill & Co first reported a position in Nu Skin in Q1 2021 and held it in 3 quarters.
Winmill & Co's Nu Skin position peaked at $4.38M in Q3 2021.
258 funds tracked by Wall St. Rank held Nu Skin as of Q4 2021.

Based on Winmill & Co's 13F filing for Q4 2021, filed 11 Feb 2022.